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Background​: More than half (57%) of pharma clinical research spend is in support of clinical 
trials. One reason is that Electronic Health Record (EHR) systems and HIPAA privacy rules 
often limit how broadly patient information can be shared, resulting in laborious human efforts to 
manually collect, de-identify, and summarize patient information for use in clinical studies.  
 
Purpose: ​Conduct feasibility study for a Rheumatoid Arthritis (RA) clinical trial in an 
Accountable Care Organization. Measure prevalence of RA and related conditions matching 
study criteria. Evaluate automation of patient de-identification and summarization to support 
patient cohort development for clinical studies.  
 
Methods: ​Collect original clinical documentation directly from the provider EHR system and 
extract clinical concepts necessary for matching study criteria. Automatically de-identify 
Protected Health Information (PHI) protect patient privacy and promote sharing. Leverage 
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existing physician expert knowledge sources to enable analysis of patient populations.  
 
Results: ​Prevalence of RA was four percent (4%) in the study population (mean age 53 years, 
52% female, 48% male). Clinical documentation for 3500 patient were extracted from three (3) 
EHR systems. Grouped diagnosis codes revealed high prevalence of diabetes and diseases of 
the circulatory system, as expected. De-identification accurately removed 99% of PHI identifiers 
with 99% sensitivity and 99% specificity.  
 
Conclusions: ​Results suggest the approach can improve automation and accelerate planning 
and construction of new clinical studies in the ACO setting. De-identification accuracy was 






Clinical trials require both sufficient numbers of human samples and samples from different 
patient populations -- a single large medical center is not sufficient no matter the size ​[​1​]​. 
Differences in patient demographics, disease prevalence, healthcare settings, coding practices, 
and health information systems all limit how broadly study results will demonstrate success for 
patients outside of the study population ​[​1​]​. To defer difficult reproducibility issues to phase III 
clinical trials would add significant time and cost.  
 
Clinical research spending is increasing year-on-year with fewer new drugs being brought to 
market. More than half (57%) of pharma clinical research spend is in support of clinical trials [​2​], 
and many clinical trials fail despite promising early findings. Nonetheless, the industry of drug 
discovery continues to grow continues to grow and is supported by Health-IT applications [​3​] for 
traditional clinical studies [​4​] and modern precision medicine [​5​]. 
 
This paper reports methods and results of extracting patient data to support clinical research [​6​], 
cohort selection, and clinical trials in diverse ACO locations. The methodology reported here 
previously aided the query and analysis of patients with Juvenile Idiopathic Arthritis (JIA) across 
60 health institutions [​7​], suggesting that the approach may be applicable to adults with arthritis 
as well.  The methodology is then validated in three real world settings to identify a target 





Patient Data Extraction For Cohort Analysis 
Patient data from Electronic Health Record (EHR) systems are extracted and translated into 
U.S. standard coded value sets [​8​] for demographics [​9​, ​10​], diagnosis [​11​], medications [​12​], 
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and procedures [​13​]. To support population level analysis [​1​] [​14​] , coded concepts were 
grouped using expert hierarchies curated by physician experts, shown in ​Table 1​.  
 
 
PATIENT DATA CODING STANDARD EXPERT GROUPING 
Diagnoses 
ICD (ICD-9-CM, ICD-10-CM) 
SNOMED Clinical Terms 





NDF-RT Drug Ingredients 
UMLS Metathesaurus 
Lab Tests LOINC LOINC Test Panels 
Demographics HL7 Core CDC Race and Ethnicity 
 
Table 1​. ​Clinical data standardization with clinical codes grouped by clinical expert knowledge.  
Diagnoses​ are extracted using SNOMED Clinical Terms or ICD codes. For historical diagnosis, 
ICD-9-CM terms are used and for recent diagnosis, ICD-10-CM terms are used. CCS Clinical 
Classifications and UMLS are used to group patients having diagnosis codes with synonymous or more 
specific meaning. ​Medications​ are extracted using RxNorm and NDC codes and mapped using 
NDF-RT into higher level groups such as “Antirheumatic Agents​” ​(NDFRT:MS100). ​Lab Tests​ are 
indexed using LOINC standards and grouped according to Lab Test panels such as “Basic Metabolic 
Panel” or “Complete Blood Count.” ​Demographics​ are defined by HL7 and patients are grouped using 
CDC Race and Ethnicity code sets. ​Other types​ of clinical data such as surgical procedures, allergies, 
and immunizations are standardized and grouped using the same approach.  
 
Patient data are extracted from EHR systems to support patient cohort selection and population 
analysis (​Figure 1​). Medal used existing EHR interfaces without customization or need for 
custom and cost intensive integration -- especially in healthcare settings where the EHR  system 
does not readily provide downloads.  
 
Medal provides a method to replace fax-based record sharing with a robust Natural Language 
Processing (NLP) system to extract machine readable coded concepts from existing EHR data. 
Medal also supports existing HL7 standards for clinical documentation architecture, especially 
Continuity of Care Documents (CCD) [​15​], Application Programming Interfaces (API), and HL7 
Fast Healthcare Interoperability Resources (HL7 FHIR) [​16​].  
 
Patient data are HIPAA de-identified to enable sharing the original clinical documentation 
between clinical research organizations. Patients are grouped using expert knowledge systems 
to enable query and analysis of higher level disease categories such as “​Diseases of the 
musculoskeletal system and connective tissue​ ” ​[​17​] ​and medications “​Antirheumatic Agents​ ” 
[​18​]. 
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Figure 1: Patient data extraction for patient cohort analysis. ​Clinical documents from 
existing EHRs are extracted using Print, CCD, and API methods. Clinical documents are then 
translated into standards, de-identified, and grouped using expert knowledge sources. Patient 
cohorts can then be easily selected and analyzed to support a wide range of clinical research 






Patient data were extracted and de-identified from three EHR systems (Practice Fusion, GE 
Centricity, and drchrono) for NACORS care providers. In total, records were extracted for 3,500 
NACORS patients (​Figure 2​). The average patient age was 53 years old and the data reflected 
a nearly even division of female (52%) and male (48%) patients (​Figure 3​). The most common 
diagnoses were “​Vitamin D Deficiency​  “​Pure Hypercholesterolemia​ ,” and “​Essential 
Hypertension​ .” Grouping patient observations using expert knowledge sources reflected known 
disease burdens in adult populations, namely diabetes and heart disease (endocrine disorders 
and diseases of the circulatory system, respectively, ​Table 2​). Rheumatoid Arthritis (RA) was 
chosen as the case study for patient cohort selection to support clinical trials. RA standard case 
definition was used to select patients with RA and patients with diseases similar to RA, 
reflecting the needs to support clinical trials with covariates, outliers, co-morbidity [​14​] , and 
patients who may have RA but not yet had a diagnosis. Prevalence of RA was ~4% in the study 
population. The results suggest the approach is useful and quickly applicable to many use 
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FIgure 2: Patient samples extracted from three EHR systems. ​Left​: 3,500 patient samples 
were extracted from Practice Fusion, GE Centricity, and drchrono. ​Right:​ 494 patient samples 




FIgure 3: Demographic breakdown for age and sex. ​Left: ​Average age for all patients was 
53 years old. ​Right:​ Age distribution by sex. There are roughly equal numbers of females and 
males in this dataset (52% vs 48%). The age distribution in the sample population for is 




Rheumatoid Arthritis (RA) was chosen as the case study for patient cohort selection to support 
clinical trials. RA standard case definition was used to select patients with RA and patients with 
diseases similar to RA, reflecting the needs to support clinical trials with covariates, outliers, 
co-morbidity, and patients who may have RA but not yet had a diagnosis.  
 
Rheumatoid Arthritis is defined by the US National Library of Medicine as “​a form of arthritis that 
causes pain, swelling, stiffness, and loss of function in your joints. It can affect any joint but is 
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common in the wrist and fingers​  ​[​19​]​”. To quantify the number of patients with RA and related 
diseases, diagnosis codes were extracted and analyzed using SNOMED Clinical Terms and the 
International Classification of Diseases (ICD). Cases of RA were defined as any physician 
documentation related to the SNOMED Clinical Term “Rheumatoid Arthritis”, including related 
concepts more specific than SNOMED codes 156471009 or 69896004. For ICD-10-CM 
diagnosis, “Rheumatoid Arthritis with rheumatoid factor”[​20​] provided 281 diagnosis codes. To 
select groups of patients with RA and related diseases, patients were combined into a larger 
group in the category “Diseases of the musculoskeletal system and connective tissue”, defined 
by the expert knowledge source “Clinical Classification System”.  
 
The sample adult population had high rates (61%) of “​Endocrine; nutritional; and metabolic 
diseases and immunity disorders​ ”, mostly due to diabetes and associated co-morbidities. 
Similarly, about half (47%) of patients had at least one diagnosis in the category “​Diseases of 
the circulatory system​ ”. Relevant to the study of RA, about one third (36%) of patients had a 
diagnosis in the category “​Diseases of the musculoskeletal system and connective tissue.​ ” 
 
PERCENTAGE DIAGNOSIS CATEGORY 
61% Endocrine; nutritional; and metabolic diseases and immunity disorders 
47% Diseases of the circulatory system 
39% Diseases of the respiratory system 
36% Diseases of the musculoskeletal system and connective tissue 
33% Symptoms; signs; and ill-defined conditions and factors influencing health status 
31% Diseases of the digestive system 
31% Nutritional deficiencies 
29% Mental Illness 
28% Diseases of the nervous system and sense organs 
28% Diseases of the genitourinary system 
23% Disorders of lipid metabolism 
19% Diseases of the blood and blood-forming organs 
18% Other nutritional; endocrine; and metabolic disorders 
17% Other non-traumatic joint disorders 
17% Medical examination/evaluation 
16% Essential hypertension 
 
Table 2: Prevalence of top 15 diagnosis groups for NACORS sample patient population. 
Prevalence is the percentage of patients who have at least one recorded diagnosis in the 
diagnosis group defined by expert knowledge sources (Unified Medical Language System and 
Clinical Classification System).  
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Medal signed Business Associates Agreements (BAA) authorizing the collection, 
de-identification, and analysis of patient data from NACORS physician locations. The BAA 
authorized collection of patient data, including Protected Health Information (PHI). Medal 
de-identification (DEID) methods achieve industry best practice compliance and security. HIPAA 
defined Limited Data Sets (LDS) allows for sharing of patient data that can be linked back ​[​21​] ​to 
original sources, making it possible to identify and consent patients for clinical trials through the 
primary care physician. Human expert review was conducted on a sample of 1,224 Protected 
Health Identifiers within the extracted clinical documentation, resulting in DEID 98.7% sensitivity 
and 99.1% specificity.  De-identification accuracy was better than previously approved 
requirements defined by four (4) hospital Institutional Review Boards ​[​22​].  
 
 
Figure 4. HIPAA De-identification example. ​Protected Health Identifiers were extracted and 
redacted from clinical documents. PHI and DEID records are stored separately and linked using 
the policies defined by HIPAA Limited Data Set (LDS). Human review confirmed that diagnosis 
and other clinical concepts were preserved and not redacted from de-identified records. Model 
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Patient data from routine clinical encounters represent a vast and underutilized resource to 
support clinical research including trials in patients ​[​1​, ​2​]. Over the last decade, adoption of 
Electronic Health Record (EHR) systems has approached nearly 100% in the United States ​[​24​]​. 
Despite this remarkable achievement, the ability to share and analyze patient data across 
healthcare organizations is often limited. 
 
Variation in healthcare settings and EHR systems often limits how easily patient data can be 
shared and commonly analyzed ​[​1​]​. In general, physicians on a single EHR system at a large 
Academic Medical Center (AMC) can share patient data more easily with one another than 
providers on different EHR systems in an Independent Physicians Association (IPA) or 
Accountable Care Organization (ACO). As a result, providers in ACO locations often continue to 
rely on the fax machine, the lowest common denominator for patient data sharing. Alternatives 
to the fax machine range from structured EHR integrations to manual human labor, carrying 
heavy financial and administrative burdens.  
 
In order to support clinical trials of RA, multiple physicians and patient populations are needed 
to share patient samples in sufficient numbers for clinical investigation. RA affects less than 1 
percent ( <1% ) of patients in the United States  and at varying rates in different patient groups 
[​25​]​. Prior studies report RA disease prevalence varying by sex ​[​26​]​, age, race, and location, 
making it all the more pressing to obtain patient samples across different healthcare settings 
[​25​]​. The approach reported here was useful in the creation of a patient registry for Juvenile 
Idiopathic Arthritis with 60 health institutions [​7​].  
 
Prior work in clinical trials support has primarily focused on large medical centers using complex 
EHR systems that are generally not available to small provider practices in ACO settings. 
Nevertheless, the need to engage patients for clinical trials through a Primary Care Physician 
(PCP) remains paramount ​[​2​]​. For clinical trial site selection phase, it may be sufficient to select 
patient cohorts from billing and administrative records. Once the patient population has been 
identified, it is then necessary to examine the complete patient history, which is typically only 
available in the original EHR clinical documentation, including the physician notes.  
 
In this study, the authors extracted, de-identified, and summarized records from three (3) EMR 
systems for a study population of 3,500 patients. Queries were performed to analyze patient 
demographics and inclusion/exclusion criteria for clinical studies of RA (rheumatoid arthritis). 
Patients matching the strict definition for RA were discovered as well as patients with similar 
disease characteristics such as comorbidities relevant to the study of RA. The results suggest 
that this approach is reproducible to many disease areas and can be performed quickly and 
inexpensively for clinical studies.  
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